GDI2

GDI2 is a cytosolic regulator of the Rab GTPase cycle that extracts GDP-bound, geranylgeranylated Rab GTPases from membranes to maintain them in inactive cytoplasmic pools, thereby governing membrane trafficking (PMID:39730330). It binds Rab1A directly, and disrupting this interaction collapses ER-to-Golgi vesicular transport, producing ER dilation, ER stress, the unfolded protein response, and paraptotic cell death (PMID:37885576). GDI2 activity is chemically tunable: itaconate alkylates cysteines 203, 335, and 414 to block Rab extraction and retain Rabs on membranes (PMID:39730330), and the small molecule BQZ-485 engages Tyr245 to abolish the GDI2–Rab1A interaction (PMID:37885576). Through control of Rab-dependent trafficking, GDI2 directs the intracellular routing of amyloid precursor protein, with neuronal GDI2 loss shifting APP toward the ER and away from the Golgi and endosomes to lower Aβ production (PMID:38382624). GDI2 also physically interacts with RAB5A, and its loss elevates free RAB5A to engage p53–p21 signaling and impose G0/G1 arrest (PMID:39323841). Complete loss of Gdi2 in mice causes early embryonic lethality with widespread caspase-3–dependent cell death, establishing the gene as essential for development and cell survival (PMID:35689892).

1. 2007 Medium

   Establishing that GDI2 is subject to oxidative/nitrative post-translational modification under tissue stress raised the question of whether such modifications alter its trafficking function.

   Evidence Mass spectrometry of modified GDI2 peptides from a rat spinal cord injury model

   PMID:17315910

   Open questions at the time

   • No functional consequence of the 3-aminotyrosine or acrolein modifications was tested
   • Modified residues not linked to Rab-binding or extraction activity
2. 2020 Low

   Identifying GDI2 as a direct miR-15b-5p target connected its expression level to tumor cell invasion, but left the downstream effector route unresolved.

   Evidence Dual-luciferase reporter assay with miRNA over/under-expression and GDI2 rescue in thyroid carcinoma cells

   PMID:32945458

   Open questions at the time

   • Biochemical link from GDI2 to MMP2/MMP9 not established
   • No connection to the Rab-extraction mechanism
   • Single lab, single cancer context
3. 2021 Low

   GDI2 knockdown phenotypes in prostate cancer associated the protein with proliferation and apoptosis control via p75NTR, framing it as a candidate cancer dependency.

   Evidence shRNA knockdown with proliferation/apoptosis assays and p75NTR/NF-κB readouts plus xenograft

   PMID:34051575

   Open questions at the time

   • Mechanistic link between GDI2 and p75NTR not biochemically established
   • Single method per endpoint
   • No connection to Rab cycling demonstrated
4. 2022 Medium

   Defining the consequence of total GDI2 loss in vivo answered whether the gene is essential, showing it is required for embryonic survival.

   Evidence Gdi2 null mouse with histology, TUNEL, and cleaved caspase-3 staining

   PMID:35689892

   Open questions at the time

   • Which Rab-dependent trafficking step underlies the lethality is not defined
   • Cell-type origin of the apoptotic phenotype not pinpointed
   • No rescue experiment
5. 2023 High

   Pinpointing a direct GDI2–Rab1A interaction and a druggable Tyr245 site mechanistically tied GDI2 to ER-to-Golgi transport and to ER-stress-driven cell death.

   Evidence Activity-based protein profiling, NanoLuc screening, Co-IP/pulldown, BQZ-485 pharmacology and xenograft

   PMID:37885576

   Open questions at the time

   • Whether Rab1A is the sole client mediating the paraptotic phenotype is unresolved
   • Structural basis of the Tyr245-dependent interaction not solved
6. 2024 High

   Identifying itaconate alkylation at Cys203/335/414 defined a physiological switch that inhibits GDI2-mediated Rab extraction, linking metabolite signaling to membrane Rab retention and viral infection.

   Evidence Activity-based alkylation assay, cysteine-mutant validation, GGTase-II dependence, in vivo and single-cell RNA-seq

   PMID:39730330

   Open questions at the time

   • Which specific Rab clients are most affected by alkylation in vivo not fully enumerated
   • Quantitative impact on distinct trafficking routes not resolved
7. 2024 Medium

   Connecting GDI2 to APP routing and to RAB5A/p53 signaling extended its trafficking role into disease-relevant outputs (Aβ production and cell-cycle control).

   Evidence Neuron-specific Gdi2 KO in 5xFAD mice with APP co-localization and Aβ assays; reciprocal Co-IP of GDI2-RAB5A with epistasis rescue in colorectal cancer cells

   PMID:38382624 PMID:39323841

   Open questions at the time

   • Whether APP rerouting is a direct Rab effect or indirect not dissected
   • How GDI2 loss increases free RAB5A to activate p53 mechanistically unresolved
   • Cross-tissue generality not tested

• The full spectrum of GDI2 Rab clients and how client selectivity dictates distinct trafficking and disease outcomes remains unresolved.
• No comprehensive map of GDI2-extracted Rabs across cell types
• Structural model of GDI2-Rab membrane extraction not established in this corpus
• Causal Mendelian disease link absent from the corpus